Latest Diabetes Stories

Transitions Optical Educates Consumers About Proper Eye Care and the Connection Between Vision and Diabetes NEW YORK, March 5, 2013 /PRNewswire/ -- Transitions Optical, Inc. in partnership with Davis Vision optical retail stores, will join the American Diabetes Association (ADA) in New York City to educate and motivate consumers to visit an eyecare professional regularly for comprehensive eye exams that help with the early detection of diabetes and the development of certain vision...

INDIANAPOLIS, March 5, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a conference call for the media and investment community to provide a pipeline update for its diabetes business on Monday, June 24, 2013. The call, which is being held in conjunction with the 73(rd) American Diabetes Association Scientific Sessions, will include updates on Phase III data for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor, and dulaglutide, an...

Achievement marks key progress toward European regulatory trials OXFORD, England, March 5, 2013 /PRNewswire/ -- GlySure Limited, developer of in-hospital continuous blood glucose monitoring systems, today announced that it has achieved ISO 13485 certification, the global standard for the requirements of a quality management system for the design, manufacture and distribution of medical devices. By establishing a quality management system that meets international regulatory and...

OneTouch® Verio®Sync Meter With Mobile App Allows Patients To Easily View and Share Blood Sugar Information Using Their iPhone®, iPad® or iPod touch® MILPITAS, Calif., March 4, 2013 /PRNewswire/ -- LifeScan, Inc. announced today that the OneTouch® Verio®Sync Blood Glucose Monitoring System has received clearance from the US Food & Drug Administration (FDA). It is the first meter to automatically send blood glucose results wirelessly via Bluetooth technology to an iPhone,...

BRIDGEWATER, N.J., March 4, 2013 /PRNewswire/ -- The American Diabetes Association announced that Tara Charvat of Valeritas, was named Marketing Communications Chair of the Community Leadership Board (CLB) for the Northern New Jersey office of the American Diabetes Association. As Marketing Communications Chair, Tara Charvat will provide leadership and direction to the Northern New Jersey Market Community Leadership Board to support annual American Diabetes Association goals...

Provides Comprehensive Wound Care and Limb Salvage to Greater Los Angeles (PRWEB) March 03, 2013 Dr. Bill Releford, a leader in the field of diabetic limb preservation and wound care, is pleased to announce the Releford Foot and Ankle Institute has found a new home at 9735 Wilshire Boulevard. From this central location, the Institute will be able to better serve those in need of foot and ankle care. “At the Releford Foot and Ankle Institute, we treat diabetic neuropathy, non-healing...

Platelet-rich plasma therapy relieves chronic swelling, reduces pain. Los Angeles, CA (PRWEB) March 02, 2013 Until now, patients with lymphedema turned to compression and/or physical therapy for relief from this chronic inflammatory condition and its associated wounds. Thanks to a pioneering treatment developed by Dr. Bill Releford, D.P.M, they have another option: platelet-rich plasma therapy (PRP). By using proprietary PRP injections, Dr. Releford’s protocol reduces the pain and...

A 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naive subjects with Type 2 Diabetes. The total duration of the trial is approximately 29 weeks consisting of a 2 week screening period, 26 weeks of treatment and a follow-up visit 1 week after treatment. Birmingham, Alabama (PRWEB) February 28, 2013 *Achieve Clinical Research conducts Clinical Trials in Birmingham, Alabama. For more information about getting started with a...

New research led at the University of Leicester reveals that individuals at high risk of developing type 2 diabetes would benefit from being told to sit less and move around more often- rather than simply exercising regularly. The experts suggest that reducing sitting time by 90 minutes in total per day could lead to important health benefits. Currently, at risk patients are advised to engage in moderate-to-vigorous physical activity (MVPA) for at least 150 mins per week. But the new study...

- Data presented at international diabetes conference suggest PaQ® device may offer safe, highly satisfying alternative to multiple daily insulin injections - HORW, Switzerland, Feb. 28, 2013 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that initial data from a study of the company's PaQ(® )Insulin Delivery Device were presented today at the 6(th) International Conference on Advanced Technologies...